Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 30.8B | 25.1B | 26.1B | 21.8B |
Cost of revenue | 17.4B | 14.0B | 14.4B | 12.3B |
Gross profit | 13.4B | 11.1B | 11.7B | 9.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 7.1B | 6.0B | 5.7B | 5.2B |
Operating income | 2.5B | 1.5B | 2.4B | 1.1B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 312.5M | 286.6M | 293.9M | 274.5M |
Other income expense | — | — | — | — |
Pretax income | 3.0B | 1.6B | 2.7B | 1.6B |
Tax provision | 950.9M | 425.4M | 682.5M | 518.9M |
Net income | 2.1B | 1.1B | 2.0B | 1.1B |
Basic EPS | — | 10.3 | 17.5 | 10.3 |
Diluted EPS | — | 10.3 | 17.5 | 10.3 |
Basic average shares | — | 112.6M | 112.7M | 112.7M |
Diluted average shares | — | 112.6M | 112.7M | 112.7M |
EBITDA | 3.8B | 2.2B | 3.4B | 2.2B |
Net income from continuing op. | — | — | — | — |
Minority interests | 1.8M | 21.7M | -9.7M | 63.9M |
Preferred stock dividends | 0 | 0 | 0 | 0 |